Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoventry Bs12e% Regulatory News (CVBP)

Share Price Information for Coventry Bs12e% (CVBP)

Share Price is delayed by 15 minutes
Get Live Data
190.875    0.00 (0.00%)
Bid:
187.75
Ask:
194.00
Spread: 6.25 (3.329%)
Market Cap: -
CVBP Live PriceLast checked at - London Stock Exchange

Intraday Coventry Bs12e% Share Chart

Coventry Building Society Capital Update

11 Dec 2019 18:18

RNS Number : 5874W
Coventry Building Society
11 December 2019
Β 

Coventry Building Society capital update.

This announcement contains inside information

11 December 2019

Capital update

Coventry Building Society (the "Society") announces a correction to its calculation of risk weighted assets. This lowers its Common Equity Tier 1 ("CET1") ratio reported at 30th June 2019 by 1.6% to 32.6% from 34.2%1.

The Society uses Internal Ratings Based ("IRB") models to calculate its Risk Weighted Assets ("RWAs") and is seeking to update these models to ensure compliance with upcoming Basel III reforms2. During the process of transitioning models, the Society has identified an omission in connection with its historic calculation of its RWAs. Specifically, the necessary 6% scalar was not applied to the core IRB model outputs. The core IRB models themselves are not impacted. Application of the 6% scalar would have increased total RWAs by 4.6%, resulting in the 1.6% reduction in the CET1 ratio, as at 30th June 2019. The previous guidance provided by the Society on the transitional and end-state impact on its CET1 ratio of standardised floors within Basel IV remains unchanged.

The Society maintains a simple and low risk business model and expects that its CET1 ratio will continue to be one of the highest reported in the UK, reflecting a considerable capital surplus above regulatory requirements. These updates do not affect the leverage ratio, which the Society expects to be its binding capital measure in future.

Inside information noticeΒ 

This announcement relates to the disclosure of information that qualified, or may have qualified, as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation (Regulation (EU) No. 596/2014) ("MAR"). For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, the person responsible for arranging the release of this announcement on behalf of Coventry Building Society is Michele Faull, Chief Financial Officer.

Media enquiries should be directed to:

Richard Field

Head of Communications

0800 121 6868

Β 

Please note that revised capital tables can be viewed on the Society's website: https://www.coventrybuildingsociety.co.uk/consumer/our-performance/financial-results/archive.htmlΒ 

Β 

Β 

1 As at 30 June 2019Β 

2 Also commonly referred to as Basel IV

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
UPDUAAWRKOAUAAA
Date   Source Headline
17th Nov 20223:07 pmRNSPublication of Final Terms
22nd Sep 20227:00 amRNSPublication of Final Terms
12th Sep 202210:48 amRNSPublication of Suppl.Prospcts
29th Jul 20227:00 amRNSHalf-year Report
25th Jul 20224:32 pmRNSRedemption of Covered Bonds
4th Jul 20221:01 pmRNSPublication of Final Terms
31st May 202210:38 amRNSPublication of a Prospectus
4th May 20223:52 pmRNSChange of Principal Office Address
10th Mar 20224:09 pmRNSPublication of Suppl.Prospcts
25th Feb 20227:00 amRNSFinal Results
8th Feb 20224:24 pmRNSPublication of a Prospectus
7th Feb 20227:30 amRNSAppointment of Chair Designate
22nd Dec 20212:28 pmRNSPublication of a Prospectus
3rd Nov 202110:10 amRNSRedemption of Covered Bonds
18th Oct 20215:55 pmRNSPublication of Suppl.Prospcts
1st Oct 20217:45 amRNSRetirement of Chair of the Board
29th Jul 20217:00 amRNSHalf-year Report
9th Jul 202110:07 amRNSPublication of Final Terms
18th Jun 20215:50 pmRNSPublication of Final Terms - Replacement
18th Jun 20215:13 pmRNSPublication of Final Terms
20th May 20215:59 pmRNSPublication of Suppl.Prospcts
26th Apr 20214:45 pmRNSIssue of Debt
8th Apr 20212:59 pmRNSPublication of Suppl.Prospcts
1st Apr 20219:10 amRNSCFO Appointment
8th Mar 20212:04 pmRNSPublication of Suppl.Prospcts
8th Mar 20212:04 pmRNSPublication of Suppl.Prospcts
5th Mar 202110:47 amRNSPublication of Suppl.Prospcts
4th Mar 20217:00 amRNSFinal Results
8th Feb 20211:46 pmRNSPortfolio purchase announcement
15th Jan 20215:05 pmRNSAppointment of Non-Executive Director
22nd Dec 20205:51 pmRNSRetirement of Deputy Chair
22nd Dec 20204:42 pmRNSPublication of a Prospectus
5th Nov 20209:00 amRNSInterim CFO
22nd Oct 20209:30 amRNSDirectorate Change
19th Oct 20203:31 pmRNSIssue of Debt
15th Oct 20203:11 pmRNSPublication of Final Terms
15th Oct 202012:33 pmRNSPublication of a Prospectus
7th Oct 202010:00 amRNSDirectorate Change
2nd Oct 20205:09 pmRNSIssue of Debt
28th Sep 20203:58 pmRNSUpdates to Covered Bond programme re: Libor
21st Sep 20205:18 pmRNSIssue of Debt
9th Sep 20203:53 pmRNSPublication of a Prospectus
28th Aug 20208:40 amRNSHalf Year Report
6th Aug 20204:07 pmRNSHalf-year Report Replacement
6th Aug 20207:00 amRNSHalf-year Report
2nd Apr 20204:22 pmRNSPublication of Final Terms
17th Mar 20202:56 pmRNSRedemption of Covered Bonds
28th Feb 20207:00 amRNSFinal Results
15th Jan 20203:00 pmRNSPublication of Final Terms
7th Jan 20202:32 pmRNSPublication of Suppl.Prospcts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.